Momanose (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momanose, is a corticosteroid presented as a nasal spray for nasal administration. It is indicated for the management of allergic rhinitis, including seasonal and perennial forms, as well as nasal polyps, providing anti‑inflammatory relief in both adult and pediatric patients.

GNH USA supplies Momanose as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide in accordance with regulatory standards and supporting local procurement teams with reliable logistics.

Momanose, a nasal corticosteroid, is used to treat inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, sneezing and itching. - Seasonal allergic rhinitis: provides symptom relief during pollen exposure. - Perennial allergic rhinitis: controls year‑round nasal inflammation. - Nasal polyps: helps shrink polyps and improve airflow.

Momanose may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation or dryness. - Cough. - Altered taste perception.

Serious or Rare Side Effects: - Adrenal suppression with prolonged use. - Glaucoma or cataract formation. - Severe allergic reaction (anaphylaxis). - Nasal septal perforation. - Opportunistic fungal infection of the nasal mucosa. - Systemic immunosuppression leading to increased infection risk.

Before using Momanose, consider the following precautions. - Assess patient history: evaluate for nasal infections or recent surgery before initiating therapy. - Avoid prolonged use: limit duration as advised by healthcare professional to reduce risk of systemic effects. - Monitor for ocular symptoms: report vision changes that could indicate glaucoma or cataracts. - Use with caution in children: follow pediatric dosing guidelines and watch for growth suppression. - Avoid concomitant intranasal decongestants: may increase local irritation. - Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Momanose may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise local drug exposure. - Live vaccines: immunosuppression may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may modestly increase exposure. - Ritonavir: may affect metabolism of the nasal corticosteroid. - Nasal antihistamines: may cause additive local irritation.